All In Biotech

Free tool

FAERS Monitor: Nuvigil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021875 or its brand name (Nuvigil, Armodafinil). Reports on generic versions are filed under their own applications.

Reports

21,062

Serious

9,699

46% of reports

Hospitalization

2,559

Death reported

326

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,579
  • fatigue1,525
  • nausea1,487
  • headache1,411
  • anxiety1,187
  • somnolence1,110
  • depression1,021
  • insomnia986
  • feeling abnormal961
  • fall897
  • dizziness880
  • weight decreased748
  • pain716
  • condition aggravated701
  • sleep apnoea syndrome629

Reports by year received

View as table
YearReports
20084
200959
2010202
2011445
20122,692
2013763
2014820
20152,028
20165,261
20171,670
20181,525
20191,432
20201,044
2021540
2022622
2023681
2024612
2025399
2026263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,097 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sleep apnoea syndromeSignal62934.031.419,470
somnolenceSignal1,1105.55.24,131
depressionSignal1,0214.54.22,791
anxietySignal1,1874.24.02,894
feeling abnormalSignal9614.03.82,191
insomniaSignal9863.73.51,964
fallSignal8972.72.5968
weight decreasedSignal7482.72.5795
condition aggravatedSignal7012.32.1523
headacheSignal1,4112.32.11,007
fatigue1,5252.01.9740
nausea1,4871.91.8632
dizziness8801.81.7296
drug ineffective1,5791.21.154
pain7161.21.117

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.